Logo image
Modification of surfactant contrast agent for targeted ultrasound imaging
Conference proceeding

Modification of surfactant contrast agent for targeted ultrasound imaging

B.E Oeffinger, J.D Lathia, N.O Dhoot, K.A Barbee and M.A Wheatley
2003 IEEE 29th Annual Proceedings of Bioengineering Conference, v 2003-, pp 305-306
2003

Abstract

Biomedical engineering Biomedical imaging Breast cancer Chemicals Computer aided analysis Drug delivery In vitro Peptides Sequences Ultrasonic imaging
Fibronectin peptide fragments were conjugated to a surfactant stabilized ultrasound contrast agent to develop a targeted contrast agent that enhances ultrasound imaging. The agent was modified with PEG and conjugated with a generic GRGDS peptide sequences that targets integrins specific to angiogenesis. The microbubbles bound to human breast cancer cells in vitro within 3 minutes under flow conditions. The GRGDS peptide modified-microbubbles show promise as candidates for targeted therapeutic imaging and eventually drug delivery vehicles.

Metrics

8 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Computer Science, Artificial Intelligence
Engineering, Biomedical
Instruments & Instrumentation
Radiology, Nuclear Medicine & Medical Imaging
Logo image